Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-07-31 Sale |
2020-08-04 7:50 pm |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
3,095 | $151.9 | $470,129 | 1,464 (Direct) |
View |
| 2020-06-18 Sale |
2020-06-22 4:42 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
18,705 | $115.2 | $2,154,851 | 100,734 (Direct) |
View |
| 2020-05-21 Sale |
2020-05-26 9:27 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
46,953 | $139.77 | $6,562,409 | 283,482 (Direct) |
View |
| 2020-05-18 Sale |
2020-05-26 9:24 pm |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
3,009 | $142.53 | $428,873 | 2,664 (Direct) |
View |
| 2020-05-20 Sale |
2020-05-21 9:08 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
517 | $139.44 | $72,093 | 119,439 (Direct) |
View |
| 2020-05-18 Sale(A) |
2020-05-21 9:06 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
1,600 | $137.78 | $220,448 | 121,717 (Direct) |
View |
| 2020-05-15 Sale |
2020-05-19 8:54 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
435 | $140.69 | $61,200 | 26,089 (Direct) |
View |
| 2020-05-15 Sale |
2020-05-19 8:47 pm |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
660 | $140.43 | $92,684 | 32,267 (Direct) |
View |
| 2020-05-18 Sale |
2020-05-19 8:46 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
1,600 | $137.78 | $220,448 | 121,717 (Direct) |
View |
| 2020-05-13 Sale |
2020-05-15 5:41 pm |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
15,394 | $128.74 | $1,981,875 | 36,013 (Direct) |
View |
| 2020-05-13 Sale |
2020-05-15 5:37 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
8,000 | $127.8 | $1,022,373 | 41,374 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-07-31 Exercise |
2020-08-04 7:50 pm |
N/A N/A |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
2,109 | $67.71 | 1,464 (Direct) |
View |
| 2020-07-31 Option Award |
2020-08-04 7:50 pm |
N/A 2029-05-15 |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
2,109 | $0 | 1,464 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 7:11 pm |
N/A 2030-06-11 |
REPLIGEN CORP | RGEN | EGLINTON MANNER CARRIE Director |
2,794 | $0 | 2,794 (Direct) |
View |
| 2020-05-21 Exercise |
2020-05-26 9:27 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
39,037 | $24.98 | 283,482 (Direct) |
View |
| 2020-05-21 Exercise |
2020-05-26 9:27 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
3,086 | $32.4 | 283,482 (Direct) |
View |
| 2020-05-21 Exercise |
2020-05-26 9:27 pm |
N/A 2024-05-05 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
50,039 | $0 | 283,482 (Direct) |
View |
| 2020-05-21 Exercise |
2020-05-26 9:27 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
7,916 | $16.55 | 283,482 (Direct) |
View |
| 2020-05-18 Exercise |
2020-05-26 9:24 pm |
N/A N/A |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
2,109 | $67.71 | 2,664 (Direct) |
View |
| 2020-05-18 Exercise |
2020-05-26 9:24 pm |
N/A 2029-05-15 |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
2,109 | $0 | 2,664 (Direct) |
View |
| 2020-05-13 Option Award(A) |
2020-05-21 9:06 pm |
2021-05-13 2030-05-13 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,483 | $0 | 121,717 (Direct) |
View |
| 2020-05-13 Option Award |
2020-05-19 8:46 pm |
2021-05-13 2030-05-13 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,483 | $0 | 121,717 (Direct) |
View |
| 2020-05-13 Option Award |
2020-05-19 8:45 pm |
2021-05-13 2030-05-13 |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,812 | $0 | 3,735 (Direct) |
View |
| 2020-05-13 Option Award |
2020-05-19 8:42 pm |
2021-05-13 2030-05-13 |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,812 | $0 | 4,849 (Direct) |
View |
| 2020-05-13 Option Award |
2020-05-19 8:42 pm |
2021-05-13 2030-05-13 |
REPLIGEN CORP | RGEN | MUIR GLENN P Director |
1,812 | $0 | 7,190 (Direct) |
View |
| 2020-05-13 Exercise |
2020-05-15 5:41 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
9,024 | $32.4 | 36,013 (Direct) |
View |
| 2020-05-13 Exercise |
2020-05-15 5:41 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
3,170 | $26.05 | 36,013 (Direct) |
View |
| 2020-05-13 Exercise |
2020-05-15 5:41 pm |
N/A 2026-02-26 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
12,194 | $0 | 36,013 (Direct) |
View |
| 2020-05-13 Exercise |
2020-05-15 5:37 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
6,000 | $33.05 | 41,374 (Direct) |
View |
| 2020-05-13 Exercise |
2020-05-15 5:37 pm |
N/A 2026-12-14 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
8,000 | $0 | 41,374 (Direct) |
View |
| 2020-05-13 Exercise |
2020-05-15 5:37 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
2,000 | $33.87 | 41,374 (Direct) |
View |